BRIEF published on 07/31/2024 at 09:05, 2 years 1 month ago Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical Drug Discovery Neurological Disorders Collaboration Agreement Systasy Bioscience Ono Pharmaceutical
BRIEF published on 07/31/2024 at 09:05, 2 years 1 month ago Systasy Bioscience annonce un accord de collaboration avec Ono Pharmaceutical Découverte De Médicament Troubles Neurologiques Accord De Collaboration Systasy Biosciences Ono Pharmaceutique
BRIEF published on 07/31/2024 at 09:05, 2 years 1 month ago Teleperformance Publishes Half-Year Financial Report for June 2024 Investor Information Half-year Financial Report 2024 Earnings Teleperformance French Market Authority
BRIEF published on 07/31/2024 at 09:05, 2 years 1 month ago Teleperformance publie son rapport financier semestriel de juin 2024 Résultats 2024 Informations Pour Les Investisseurs Rapport Financier Semestriel Teleperformance Autorité Des Marchés
BRIEF published on 07/31/2024 at 08:50, 2 years 1 month ago O'KEY Group Reports 5.2% Retail Revenue Growth in Q2 2024 Q2 2024 O'KEY Group DA! Discounters Retail Revenue Net Growth
BRIEF published on 07/31/2024 at 08:50, 2 years 1 month ago O'KEY Group annonce une croissance de 5,2 % de son chiffre d'affaires au détail au deuxième trimestre 2024 T2 2024 Groupe O'KEY DA! Discounters Revenus Du Commerce De Détail Croissance Nette
BRIEF published on 07/31/2024 at 08:47, 2 years 1 month ago Marley Spoon Group SE Reports Positive Operating EBITDA in Q2 2024 and Annual Growth to €86.8M in Net Revenue EBITDA Q2 2024 Marley Spoon Net Revenue Meal Kits
BRIEF published on 07/31/2024 at 08:47, 2 years 1 month ago Marley Spoon Group SE annonce un EBITDA opérationnel positif au deuxième trimestre 2024 et une croissance annuelle à 86,8 millions d'euros de chiffre d'affaires net BAIIA Cuillère Marley T2 2024 Kits Repas Revenu Net
BRIEF published on 07/31/2024 at 08:35, 2 years 1 month ago EcoGraf Limited Reports Quarterly Activities and Financial Updates Funding Quarterly Report EcoGraf Graphite Projects Battery Anode Materials
BRIEF published on 07/31/2024 at 08:35, 2 years 1 month ago EcoGraf Limited publie des rapports trimestriels sur ses activités et des mises à jour financières Financement EcoGraf Rapport Trimestriel Projets Graphites Matériaux D'anode De Batterie
Published on 09/12/2026 at 02:35, 4 hours 24 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 7 hours 59 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 8 hours 54 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 9 hours 34 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 13 hours 59 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 8 hours 44 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 8 hours 49 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 11 hours 15 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 12 hours 44 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 23 hours 59 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 23 hours 59 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 23 hours 59 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 23 hours 59 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 11 hours ago Availability of the 2026 Interim Financial Report
